Related references
Note: Only part of the references are listed.ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm
Mahendra Naidoo et al.
CANCERS (2021)
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
M. J. M. Magbanua et al.
ANNALS OF ONCOLOGY (2021)
Colon Cancer, Version 2.2021
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer
Alessandro Ottaiano et al.
CELL DEATH & DISEASE (2020)
The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA
Tenna V. Henriksen et al.
MOLECULAR ONCOLOGY (2020)
Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis
Alessandro Ottaiano et al.
CANCERS (2020)
The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis
Yoshikuni Kawaguchi et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review
Sakti Chakrabarti et al.
CANCERS (2020)
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
Scott V. Bratman et al.
NATURE CANCER (2020)
Clinical utility of circulating tumor DNA for colorectal cancer
Hiroki Osumi et al.
CANCER SCIENCE (2019)
Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients
Hangyu Zhang et al.
TRANSLATIONAL ONCOLOGY (2019)
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Raoul Charles Coombes et al.
CLINICAL CANCER RESEARCH (2019)
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
Emil Christensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
Thomas Reinert et al.
JAMA ONCOLOGY (2019)
Droplet digital PCR revealed high concordance between primary tumors and lymph node metastases in multiplex screening of KRAS mutations in colorectal cancer
Barbora Vanova et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2019)
Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA
Lucie Benesova et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective
Mathilde Postel et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis
Junzhong Lin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
Chiara Molinari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study
Guojun Tong et al.
CANCER MEDICINE (2018)
Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
Zhizhong Pan et al.
CANCER COMMUNICATIONS (2018)
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Maha Elazezy et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Circulating tumor DNA (ctDNA) utilizing a high-sensitivity panel to detect minimal residual disease post liver hepatectomy and predict disease recurrence.
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Blood Measurement of Carcinoembryonic Antigen Level for Detecting Recurrence of Colorectal Cancer
Brian D. Nicholson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection
Gregor Norcic et al.
ONCOLOGY LETTERS (2016)
Imaging in Colorectal Cancer: Progress and Challenges for the Clinicians
Eric Van Cutsem et al.
CANCERS (2016)
Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
Lydia G. M. van der Geest et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal Cancer
Anya Litvak et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Palliative care and end-stage colorectal cancer management: The surgeon meets the oncologist
Renato Costi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Actual 10-year survival after resection of colorectal liver Metastases defines cure
James S. Tomlinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: Implications for tumor marker monitoring and guidelines
H Sorbye et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
